MX2019000744A - Formas solidas del inhibidor de la tirosina treonina cinasa (ttk). - Google Patents
Formas solidas del inhibidor de la tirosina treonina cinasa (ttk).Info
- Publication number
- MX2019000744A MX2019000744A MX2019000744A MX2019000744A MX2019000744A MX 2019000744 A MX2019000744 A MX 2019000744A MX 2019000744 A MX2019000744 A MX 2019000744A MX 2019000744 A MX2019000744 A MX 2019000744A MX 2019000744 A MX2019000744 A MX 2019000744A
- Authority
- MX
- Mexico
- Prior art keywords
- crystal
- solid forms
- formula
- ttk inhibitor
- ttk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/54—Organic compounds
- C30B29/58—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/02—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions by evaporation of the solvent
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/14—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions the crystallising materials being formed by chemical reactions in the solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
La presente invencion se refiere a un novedoso co-cristal del compuesto de formula (I): (Formula (I)) en donde la molecula co-formadora es hemihidrato de bifosfato, a procesos para la preparacion del co-cristal, a composiciones farmaceuticas que contienen el co-cristal, al uso de tal co-cristal en la manufactura de un medicamento para uso en el tratamiento de cancer y a métodos para tratar tales enfermedades en el cuerpo humano o animal por administracion de una cantidad terapeuticamente efectiva de tal co-cristal.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662363424P | 2016-07-18 | 2016-07-18 | |
| PCT/CA2017/050848 WO2018014116A1 (en) | 2016-07-18 | 2017-07-13 | Solid forms of ttk inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019000744A true MX2019000744A (es) | 2019-05-02 |
Family
ID=60991755
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019000744A MX2019000744A (es) | 2016-07-18 | 2017-07-13 | Formas solidas del inhibidor de la tirosina treonina cinasa (ttk). |
| MX2021008658A MX2021008658A (es) | 2016-07-18 | 2019-01-17 | Formas sólidas del inhibidor de la tirosina treonina cinasa (ttk). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021008658A MX2021008658A (es) | 2016-07-18 | 2019-01-17 | Formas sólidas del inhibidor de la tirosina treonina cinasa (ttk). |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US10584130B2 (es) |
| EP (1) | EP3484888B1 (es) |
| JP (2) | JP6961675B2 (es) |
| KR (2) | KR102537088B1 (es) |
| CN (2) | CN109476667B (es) |
| AU (2) | AU2017299850B2 (es) |
| BR (1) | BR112019000813A2 (es) |
| CA (1) | CA3030230A1 (es) |
| DK (1) | DK3484888T3 (es) |
| ES (1) | ES2945108T3 (es) |
| FI (1) | FI3484888T5 (es) |
| HR (1) | HRP20230481T1 (es) |
| HU (1) | HUE061872T2 (es) |
| IL (1) | IL264173A (es) |
| LT (1) | LT3484888T (es) |
| MA (1) | MA45691A (es) |
| MX (2) | MX2019000744A (es) |
| NZ (1) | NZ749844A (es) |
| PL (1) | PL3484888T3 (es) |
| PT (1) | PT3484888T (es) |
| RS (1) | RS64210B1 (es) |
| RU (2) | RU2021124795A (es) |
| SG (2) | SG11201900113UA (es) |
| SI (1) | SI3484888T1 (es) |
| TW (2) | TWI745400B (es) |
| WO (1) | WO2018014116A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2021124795A (ru) | 2016-07-18 | 2021-09-14 | Юниверсити Хелс Нетуорк | Твердые формы ингибитора ttk |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4429604B2 (ja) | 2001-02-21 | 2010-03-10 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 診断におけるｔｔｋおよび癌における治療標的としてのｔｔｋ |
| PT1812440E (pt) | 2004-11-04 | 2011-01-25 | Vertex Pharma | Pirazolo[1,5-a]pirimidinas úteis enquanto inibidores de proteínas cinases |
| TW201107329A (en) * | 2009-07-30 | 2011-03-01 | Oncotherapy Science Inc | Fused imidazole derivative having ttk inhibitory action |
| TWI541243B (zh) * | 2010-09-10 | 2016-07-11 | 拜耳知識產權公司 | 經取代咪唑并嗒 |
| US20130303532A1 (en) * | 2010-12-17 | 2013-11-14 | Bayer Intellectual Property Gmbh | Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disorders |
| AU2013344716B2 (en) | 2012-11-16 | 2018-03-01 | University Health Network | Pyrazolopyrimidine compounds |
| JP6095857B2 (ja) * | 2013-11-15 | 2017-03-15 | ユニバーシティ・ヘルス・ネットワーク | ピラゾロピリミジン化合物 |
| RU2021124795A (ru) | 2016-07-18 | 2021-09-14 | Юниверсити Хелс Нетуорк | Твердые формы ингибитора ttk |
-
2017
- 2017-07-13 RU RU2021124795A patent/RU2021124795A/ru unknown
- 2017-07-13 KR KR1020197001829A patent/KR102537088B1/ko active IP Right Grant
- 2017-07-13 SG SG11201900113UA patent/SG11201900113UA/en unknown
- 2017-07-13 MX MX2019000744A patent/MX2019000744A/es unknown
- 2017-07-13 PL PL17830139.6T patent/PL3484888T3/pl unknown
- 2017-07-13 HU HUE17830139A patent/HUE061872T2/hu unknown
- 2017-07-13 US US16/318,426 patent/US10584130B2/en active Active
- 2017-07-13 SG SG10202103332UA patent/SG10202103332UA/en unknown
- 2017-07-13 RS RS20230383A patent/RS64210B1/sr unknown
- 2017-07-13 KR KR1020237017039A patent/KR20230074839A/ko not_active Application Discontinuation
- 2017-07-13 SI SI201731352T patent/SI3484888T1/sl unknown
- 2017-07-13 BR BR112019000813-6A patent/BR112019000813A2/pt unknown
- 2017-07-13 NZ NZ749844A patent/NZ749844A/en unknown
- 2017-07-13 FI FIEP17830139.6T patent/FI3484888T5/fi active
- 2017-07-13 CN CN201780043473.1A patent/CN109476667B/zh active Active
- 2017-07-13 HR HRP20230481TT patent/HRP20230481T1/hr unknown
- 2017-07-13 PT PT178301396T patent/PT3484888T/pt unknown
- 2017-07-13 RU RU2019101109A patent/RU2753905C2/ru active
- 2017-07-13 CA CA3030230A patent/CA3030230A1/en active Pending
- 2017-07-13 DK DK17830139.6T patent/DK3484888T3/da active
- 2017-07-13 EP EP17830139.6A patent/EP3484888B1/en active Active
- 2017-07-13 ES ES17830139T patent/ES2945108T3/es active Active
- 2017-07-13 AU AU2017299850A patent/AU2017299850B2/en active Active
- 2017-07-13 CN CN202210644487.1A patent/CN115093416B/zh active Active
- 2017-07-13 WO PCT/CA2017/050848 patent/WO2018014116A1/en unknown
- 2017-07-13 MA MA045691A patent/MA45691A/fr unknown
- 2017-07-13 JP JP2019501928A patent/JP6961675B2/ja active Active
- 2017-07-13 LT LTEPPCT/CA2017/050848T patent/LT3484888T/lt unknown
- 2017-07-18 TW TW106123975A patent/TWI745400B/zh active
- 2017-07-18 TW TW110137560A patent/TWI824313B/zh active
-
2019
- 2019-01-09 IL IL264173A patent/IL264173A/en unknown
- 2019-01-17 MX MX2021008658A patent/MX2021008658A/es unknown
-
2020
- 2020-03-02 US US16/806,392 patent/US11104681B2/en active Active
-
2021
- 2021-08-24 AU AU2021221447A patent/AU2021221447B2/en active Active
- 2021-08-27 US US17/459,725 patent/US11878980B2/en active Active
- 2021-10-13 JP JP2021167806A patent/JP7263473B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021006421A (es) | Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17). | |
| PH12018500828A1 (en) | Jak kinase inhibitor compounds for treatment of respiratory disease | |
| PH12019502436A1 (en) | 6-6 fused bicyclic heteroaryl compounds and their use as lats inhibitors | |
| NZ726366A (en) | Syk inhibitors | |
| PH12016502355B1 (en) | Pharmaceutical composition | |
| JO3784B1 (ar) | الاستخدام المشترك للاجسمام المضادة pd-1 ومضادات m-csf في علاج السرطان | |
| NZ708593A (en) | Novel pyrazole derivative | |
| BR112015023948A2 (pt) | composto de fórmula (i), composição farmacêutica, método para o tratamento e/ou prevenção de uma doença proliferativa e para a inibição ou a diferenciação do crescimento de uma célula tronco do câncer | |
| MX2008013212A (es) | 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r. | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| MY155649A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| EA201592254A1 (ru) | Производные пиразолопирролидин-4-она и их применение при лечении заболевания | |
| MX2013012588A (es) | Inhibidores de cinasa. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| MX2022000390A (es) | Derivados macrociclicos espirociclicos como inhibidores de mcl-1. | |
| EA201792341A1 (ru) | Производные пиразола, пригодные в качестве ингибиторов белка, активирующего 5-липоксигеназу (flap) | |
| MX2022005985A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
| EA201370230A1 (ru) | Новые ингибиторы rock | |
| MX2022015813A (es) | 2-amino-3-fluoro-but-3-enamidas macrociclicas como inhibidores de mcl-1. | |
| MX2019007213A (es) | Derivado de azaciclobutil triazol del grupo anular condensado, metodo de preparacion del mismo y uso del mismo en medicina. | |
| MX2009007889A (es) | Derivados de 3-cinnolincarboxamida y su uso para el tratamiento del cancer. | |
| PH12019500858A1 (en) | Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety | |
| MX2021008658A (es) | Formas sólidas del inhibidor de la tirosina treonina cinasa (ttk). | |
| MX2021006490A (es) | Compuestos heteroaromaticos como inhibidores de vanina. |